Form 8-K - Current report:
SEC Accession No. 0001493152-24-024110
Filing Date
2024-06-17
Accepted
2024-06-17 16:15:33
Documents
13
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46517
  Complete submission text file 0001493152-24-024110.txt   222742

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ltrn-20240613.xsd EX-101.SCH 3030
3 XBRL LABEL FILE ltrn-20240613_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ltrn-20240613_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3833
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 241048406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)